Savine Heavy
Brand Name: Savine Heavy
Generic Name: Bupivacaine Hydrochloride in Dextrose
Active
Registration Number
DRP-1484
Dosage Form
Solution for Intrathecal Injection
Issuance Date
August 1, 2024
Expiry Date
May 27, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength5 mg/mL (0.5% w/v)
PackagingUSP Type I Clear Glass Ampoule x 4 mL
(Box of 1's and 5's)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Local Anesthetic
A
Application
Initial (Variation) (Reconstruction)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Bupivacaine Hydrochloride in DextroseActive
Monograph: bupivacaine hydrochloride in dextrose